OpenEvidence wants to move toward “medical super-intelligence” by building specialist AI models to power its platform.

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

Investors poured into a room at #JPM26 to see how Revolution Medicines' CEO would dance around questions they knew he ...

The Trump administration has signaled plans to drop its appeal of a court order that blocked a pilot from changing payment ...

The probe began after STAT and others reported on UnitedHealth's strategies to boost profits in Medicare Advantage.

A federal judge has ordered the Trump administration to restore nearly $12 million in funding to the American Academy of ...

The federal government approved $60 billion worth of extra Medicaid funds for hospitals, doctors, nursing homes, and other ...

LAS VEGAS — It took 12 doctors at six health systems across four states to diagnose top Trump administration official Amy ...

Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...

The American College of Cardiology found uneven gains and sobering declines in heart health. "You can't treat your way out of ...

New U.S. dietary guidelines for the first time include advice for men on maintaining healthy testosterone levels.

Noubar Afeyan, one of biotech’s top investors, warned that a backlash against science in the U.S. could take “a sledgehammer” ...